title: Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370].
authors.affiliation: IBD Unit, Complesso Integrato Columbus, Fondazione Policlinico Gemelli, Università Cattolica, Rome, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Armuzzi
authors.affiliation: DIMEC, University of Bologna, Bologna, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Gionchetti
authors.affiliation: SC Gastroenterologia, AO Ordine Mauriziano, Turin, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Daperno
authors.affiliation: IBD Center, Humanitas Research Hospital, Rozzano, Milan, Italy.
authors.forename: Silvio
authors.initials: S
authors.lastname: Danese
authors.affiliation: Biomedical Department of Internal and Specialist Medicine (DIBIMIS), Division of Medicine, Villa Sofia-V. Cervello Hospital, Palermo University, Palermo, Italy.
authors.forename: Ambrogio
authors.initials: A
authors.lastname: Orlando
authors.affiliation: Unit of Gastroenterology, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy.
authors.forename: Maria Lia
authors.initials: ML
authors.lastname: Scribano
authors.affiliation: Dipartimento di Scienze Biomediche per la Salute, Università di Milano, Milan, Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Vecchi
authors.affiliation: DIMEC, University of Bologna, Bologna, Italy. Electronic address: fernando.rizzello@unibo.it.
authors.forename: Fernando
authors.initials: F
authors.lastname: Rizzello